In addition, in the bone marrow microenvironment of MDS patients, osteoblast activity is significantly reduced and TIM-3 is abnormally highly expressed in osteoblasts, and this high expression may further perturb the balance of the bone marrow ecological niche and promote disease progression (25). This evidence concerns the gene HAVCR2 and myelodysplastic syndrome.